OTCMKTS:CEOS

Psykey (CEOS) Stock Price, News & Analysis

$0.02
0.00 (0.00%)
(As of 04/24/2024 ET)
Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.03
52-Week Range
$0.01
$0.05
Volume
854,419 shs
Average Volume
569,599 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CEOS stock logo

About Psykey Stock (OTCMKTS:CEOS)

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

CEOS Stock Price History

CEOS Stock News Headlines

Wall Street Legend Issues New NVDA Warning
Legendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.
Influence of founding CEOs on companies
Wall Street Legend Issues New NVDA Warning
Legendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.
Revealed: DBJ's Most Admired CEOs for 2023, Part 1
HP CEO reveals how the AI boom may change your computer
CEOS - Psykey, Inc.
See More Headlines
Receive CEOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Psykey and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:CEOS
CIK
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Ms. Kate Monroe
    Chief Executive Officer
  • Mr. Amar Singh Bhatal
    Co-Founder, President, Secretary & Director
  • Mr. Sukhinderpaul Kalsi
    Co-Founder, CFO, Treasurer & Director
  • Jacqueline Rae Danforth
    Compliance Officer & Accountant
  • Mr. Mark Perkell
    Vice President and General Counsel
  • Mr. John Gustin
    Head of Global Business Development

CEOS Stock Analysis - Frequently Asked Questions

How have CEOS shares performed in 2024?

Psykey's stock was trading at $0.0295 at the beginning of 2024. Since then, CEOS stock has decreased by 38.6% and is now trading at $0.0181.
View the best growth stocks for 2024 here
.

Are investors shorting Psykey?

Psykey saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 15,100 shares, an increase of 529.2% from the March 15th total of 2,400 shares. Based on an average daily trading volume, of 837,500 shares, the days-to-cover ratio is presently 0.0 days.
View Psykey's Short Interest
.

How do I buy shares of Psykey?

Shares of CEOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CEOS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners